The partnership program aims to develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being.
The findings of a recent study suggest that dengue and Zika viruses are able to change their host’s odor by altering the skin microbiota.
New research offers insights into how human gut bacteria recognize sulfated glycans. The findings could help to develop interventions for diseases where sulfated glycan metabolism is altered.
New research shows that microbiota diversity appears early in infants from nonindustrial populations and could be traced back to their mothers as well as to the local environment.
The findings of a small clinical trial suggest that probiotic treatment could be used in combination with antidepressant medication to treat clinical depression.
The findings of a new research suggest that IgG in breast milk promotes immunity against intestinal pathogens and shapes the development of the gut microbiota and immune cells in early…
It's the second agreement between Boehringer Ingelheim and BiomX focused on IBD. The first one in 2020.
The findings of a new research reveal the microbiota alterations during NAFLD and suggest that gut microbes can be used as an early clinical sign of the condition.
Researchers have found that some microbes involved in inflammatory conditions produced different effects based on their interaction with different host genes and through different pathways.
Locus is developing a new class of precision engineered bacteriophage treatments for a diverse set of bacterial diseases.
